December 13, 2018 09:47 AM IST
The breadth of the market favoured the advances with 1159 stocks advancing and 388 declining while 491 remained unchanged. On the BSE, 1189 stocks advanced, 348 declined and 58 remained unchanged.
December 11, 2018 12:52 PM IST
Liva Pharmaceuticals, a wholly-owned subsidiary of Cadila Healthcare, has received approval from the US Food and Drug Administration (USFDA) for its supplemental abbreviated new drug application, Ranitidine Injection USP, 25 mg/mL, 2 mL single dose vials and 6 mL multi-dose vials, Cadila Healthcare said in a BSE filing.
December 11, 2018 10:55 AM IST
Strides Vivimed Pte Ltd, Singapore, a 50:50 joint venture with Vivimed Labs, has received approval from the United States Food & Drug Administration (US FDA) for Albendazole tablets in the strength of 200 mg, Strides Pharma Science said in a BSE filing.
December 11, 2018 10:18 AM IST
200 stocks have hit fresh 52-week low on the NSE as market sentiment remains weak. The stocks to hit the new 52-week low in this morning session included NMDC, Tata Steel, Vodafone Idea, Mahindra & Mahindra, ONGC, Oil India and Cipla.
December 10, 2018 04:13 PM IST
The uncertainity over state election results and the decision of oil producing countries to cut supply by 1.2 million barrels per day from January along with global sell-off led to the bloodbath
December 10, 2018 12:23 PM IST
The breadth of the market favoured the declines with 295 stocks advancing and 1358 declining while 415 remained unchanged. On the BSE, 510 stocks advanced, 1742 declined and 116 remained unchanged.
December 10, 2018 11:36 AM IST
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solution USP, 0.1 percent, Alembic Pharmaceuticals said in a filing to BSE.
December 10, 2018 10:25 AM IST
The breadth of the market favoured the declines with 223 stocks advancing and 1407 declining while 434 remained unchanged. On the BSE, 343 stocks advanced, 1589 declined and 83 remained unchanged.
December 06, 2018 03:29 PM IST
The realty and IT index were the biggest losers that shed over 2 percent
December 06, 2018 03:01 PM IST
"The directors of the company have constituted a search and selection committee for the appointment of chief executive officer of the company," Reliance Capital said in a regulatory filing.
December 06, 2018 11:07 AM IST
Stocks to have hit fresh 52-week low on the BSE included names like Punj Lloyd which fell 14 percent followed by VIP Clothing, IL&FS Engineering and Quess Corp Ltd. which shed over 4 percent each.
December 05, 2018 11:55 AM IST
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Candesartan Cilexetil tablets USP in the strengths of 4 mg, 8 mg, and 16 mg, Alembic Pharmaceuticals said in a filing to BSE.
November 30, 2018 07:35 PM IST
"BSE to launch 'BSE-Direct' for retail investors in non-competitive bidding of G-sec and T-bills from December 03, 2018," the exchange said in a Friday release.
November 30, 2018 06:36 PM IST
The currency ended the session at 69.58 per US dollar, a gain of 26 paise (0.38 percent).
November 29, 2018 02:41 PM IST
The company's wholly-owned subsidiary has entered into a stock purchase agreement to acquire 534,194 shares of common stock of biotechnology firm Inipharm Inc USA, for a cash consideration of USD 534.20 per share, Jubilant Life Sciences said in a filing to BSE.
November 29, 2018 09:39 AM IST
The breadth of the market favoured the declines with 983 stocks advancing and 529 declining while 520 remained unchanged. On the BSE, 874 stocks advanced, 442 declined and 58 remained unchanged.
November 28, 2018 04:37 PM IST
The platform will facilitate the listing of companies in sectors like IT, ITeS, bio-technology and life sciences, 3D printing, space technology and e-commerce.
November 27, 2018 02:49 PM IST
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Baclofen tablets in the strengths of 10 mg and 20 mg, Zydus Cadila said in a filing to BSE.
November 27, 2018 09:35 AM IST
The breadth of the market favoured the advances with 745 stocks advancing and 712 declining while 569 remained unchanged. On the BSE, 684 stocks advanced, 624 declined and 67 remained unchanged.
November 26, 2018 07:17 PM IST
The company produced 9.64 MT iron ore from its mines in Chhattisgarh, while its production from Karnataka mines stood at 5.83 MT, NMDC said in a filing to BSE.
November 26, 2018 01:27 PM IST
From the personal care space, the top gainers included Colgate Palmolive (India) which jumped 2 percent followed by Dabur India, up 3.39 percent and Hindustan Unilever adding 2.86 percent.
November 23, 2018 03:47 PM IST
"The subscription CPSE ETF FFO-3 will commence from Wednesday, November 28, till Friday November 30, on BiMF (BSE iBBS Platform for Mutual Fund) module on iBBS platform of BSE," the exchange said in a circular.
November 22, 2018 03:32 PM IST
The Ahmedabad-based group has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 10 mg, 20 mg, 40 mg and 80 mg, Zydus Cadila said in a statement.
November 22, 2018 12:14 PM IST
The breadth of the market favoured the advances with 934 stocks advancing and 717 declining while 410 remained unchanged. On the BSE, 1251 stocks advanced, 1017 declined and 138 remained unchanged.
November 22, 2018 09:37 AM IST
The breadth of the market favoured the advances with 957 stocks advancing and 531 declining while 541 remained unchanged. On the BSE, 850 stocks advanced, 456 declined and 54 remained unchanged.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
